Today: 14 May 2026
Nike Stock Gets a Fresh Institutional Signal. The Market Still Looks Split
11 May 2026
2 mins read

Nike Stock Gets a Fresh Institutional Signal. The Market Still Looks Split

New York, May 11, 2026, 08:59 EDT

Nicholas Company Inc. found itself in the spotlight Monday when market chatter zeroed in on its 123,652-share stake in Nike. That position stands out as short interest climbs and analysts raise new flags on the stock. According to a May 4 SEC filing, Nicholas owned 123,652 Nike Class B shares valued at $6.53 million as of March 31.

The clock is ticking for Nike as CEO Elliott Hill works to shore up investor confidence with the stock languishing close to multi-year lows and competitors tightening the screws in both running and lifestyle shoes. Short interest has jumped—Reuters flagged last week that by May 1, 4.67% of Nike’s shares were out on loan, a standard measure of short selling.

Fresh disclosures are fueling the conversation around Nike: while some funds and insiders keep upping their bets, skepticism lingers on Wall Street about the pace of the company’s rebound. According to MarketBeat, Nicholas boosted its position by 33.3% in Q4, snapping up 30,890 shares. El-Balad highlighted the same investor, mentioning a 123,652-share holding and noting the stake was raised as Nike’s stock continued trading near the bottom of its 52-week band.

Form 13F filings land each quarter, listing what institutional investors held at the end of that period—no insight into trade motives or whether those positions remain. In Nicholas’ March-quarter report, Nike showed up as a modest position, dwarfed by bigger bets on tech and consumer stocks.

Nike was changing hands at $44.14 ahead of the New York open Monday, putting its market cap near $65.4 billion. Shares hovered just above the 52-week low of $42.09 detailed in market reports, a sharp drop from the $80.17 high for the same period.

There’s more than just chart worries here. Wells Fargo downgraded Nike to Equal Weight from Overweight and chopped its price target to $45, down from $55, citing concerns that the rise of GLP-1 weight-loss drugs could pull spending away from athletic gear toward standard apparel. GLP-1s—used for diabetes and weight management—may also push consumers to rethink their wardrobes as they slim down.

Nike’s latest results paint a complicated picture. For its fiscal third quarter, revenue came in at $11.3 billion—unchanged from a year earlier, and slipping 3% once currency effects are stripped out. Gross margin slid to 40.2%, down 130 basis points. “The work is not finished,” Hill said in the company’s statement, though he credited some progress to the Win Now plan’s impact. Nike Investors

Support appears visible among company insiders. According to SEC filings, Hill picked up 23,660.235 shares of Nike Class B on April 13, paying a weighted average of $42.27 per share. Director John W. Rogers Jr. also stepped in, acquiring 4,000 shares at $43.34 on April 9.

Competition is tightening. Nike’s grip on the global sports footwear market slid again, according to Reuters, dropping to 22.9% in 2025—that’s three years running in the wrong direction—while Adidas picked up ground, climbing to 12.2%. Meanwhile, smaller brands including On Running and Hoka parent Deckers are making inroads as Nike continues to clear older stock and looks for ways to revive demand for fresh products.

David Swartz, an analyst at Morningstar, told Reuters that “the same problems” have been on investors’ minds since Hill stepped in as CEO. Over at Flossbach von Storch, portfolio manager Simon Jaeger acknowledged some improvement, but said he’s looking for it to move beyond a handful of isolated wins. That gets right to what the market wants to know: it’s not a question of Nike’s ability to deliver occasional successes, but whether it can do it consistently enough to mend margins. Reuters

Nike’s been sending money back to its shareholders. On May 4, the company announced its board approved a quarterly dividend payout of 41 cents per share, with payment due on July 1 to those holding shares by June 1. That’s a steady income stream, but the bigger question—future growth—remains unresolved.

The danger here is that the institutional buying signal is either outdated or simply too minor to make a difference. A 13F filing only shows past moves, and short sellers have been turning up the heat. Nike still faces the challenge of delivering on product launches, clearing out inventory, and reigniting demand in China—all at once. Miss on those fronts, and the shares could remain undervalued longer than value-seekers hope.

Stock Market Today

  • ASX Showdown: Comparing Major Bank Stocks CBA and Big Miners BHP, Plus CSL Update
    May 13, 2026, 9:13 PM EDT. In a recent ChartWatch *LIVE* webinar, technical analyst Carl Capolingua broke down key ASX sectors, focusing on big banks vs. mining stocks. Detailed reviews covered Commonwealth Bank of Australia (CBA), National Australia Bank, and Westpac, alongside miners like BHP, Rio Tinto, and Fortescue Metals. Capolingua also analyzed the lithium sector and covered CSL, a major Australian biotech firm. The session highlighted how to use technical analysis for portfolio decisions amidst shifting market conditions. This weekly webinar engages hundreds of investors eager to apply trend-following methods to their holdings, emphasizing real-time stock cases across sectors.

Latest articles

Enovix Stock Drops After Q1 Beat as Smartphone Battery Tests Stay Unfinished

Enovix Stock Drops After Q1 Beat as Smartphone Battery Tests Stay Unfinished

14 May 2026
Enovix shares dropped 12.9% to $6.35 after hours Wednesday despite beating first-quarter revenue and adjusted-loss estimates. The decline followed news that smartphone battery qualification remains unfinished, with the company passing 72 of 75 customer tests. Revenue rose 49% to $7.6 million. Enovix cited progress in defense, industrial, and smart-eyewear sales.
Lightwave Logic Stock Jumps as AI-Photonics Bet Heads for a 2027 Production Test

Lightwave Logic Stock Jumps as AI-Photonics Bet Heads for a 2027 Production Test

14 May 2026
Lightwave Logic reported Q1 revenue up 27% to $29,000 and a net loss widening to $6.3 million. Shares rose 14% after the company said it is negotiating a supply and licensing deal for high-volume production in 2027. Four Fortune 500 customers are now in Stage 3 prototyping. Cash and equivalents totaled about $100 million as of May 11.
USA Rare Earth Stock Watch: Q1 Revenue, $1.75 Billion Cash and the China Supply Crunch

USA Rare Earth Stock Watch: Q1 Revenue, $1.75 Billion Cash and the China Supply Crunch

14 May 2026
USA Rare Earth reported Q1 revenue of $5.7 million and a net loss of $67 million, ending March with $1.75 billion in cash after a $1.5 billion PIPE. The company expects to sign documents this month for $1.6 billion in U.S. Commerce Department funding. Texas awarded a $14.18 million grant for the Round Top project. USA Rare Earth agreed in April to acquire Brazil’s Serra Verde for $2.8 billion.
Social Security May 2026 Payments Hit This Week: Who Gets Paid On May 13, And Who Waits
Previous Story

Social Security May 2026 Payments Hit This Week: Who Gets Paid On May 13, And Who Waits

IREN Stock’s Nvidia Rally Just Hit a $2 Billion Debt Test
Next Story

IREN Stock’s Nvidia Rally Just Hit a $2 Billion Debt Test

Go toTop